Research on the Investment Value of the Healthcare Industry: Analysis of Azenta, Universal Health Services, and Regeneron Pharmaceuticals

Tai Ren

doi:10.54097/hbem.v4i.3444

Authors

Tai Ren

DOI:

https://doi.org/10.54097/hbem.v4i.3444

Keywords:

Healthcare sector, Stock market, Investment value, Risk, Profitability

Abstract

Nowadays, investors pay more attention to investing in different fields in order to generate significant value. There are numerous sectors in the stock market that have different characteristics, but it is obvious that there would be a shift, no matter good or bad, happening in the healthcare sector during the pandemic period. By collecting data of multiple ratios and factors from professional statistics websites including Yahoo Finance and Macrotrends, this paper focuses on three leading stocks in the healthcare sector by analyzing the risk, profitability, and investment value to produce a suitable investment strategy during post-covid-19 for the three stocks, thus applying it to the whole healthcare sector. The result shows that the healthcare sector, especially some fields in it, is worthy to invest. This paper provides a very distinct representation of stock analysis based on rigorous statistics, thereby the investors can come up with a preliminary investment plan for the present healthcare stock market. This paper will be an elementary analysis of healthcare in the US stock market today and provide valuable suggestions for investors.

Downloads

Download data is not yet available.

References

Deloitte. "2020 global health care outlook, https://documents.deloitte.com/insights/2020globalhealthcareoutlook " Pages 2 & 7-8.

Forehand, A. (2000). Mission and organizational performance in the healthcare industry. Journal of healthcare Management, 45(4), 267-277.

Taner, M. T., Sezen, B., & Antony, J. (2007). An overview of six sigma applications in healthcare industry. International Journal of health care quality assurance.

Lee, S. M., Lee, D., & Schniederjans, M. J. (2011). Supply chain innovation and organizational performance in the healthcare industry. International Journal of Operations & Production Management.

Mazur, M., Dang, M., & Vega, M. (2021). COVID-19 and the march 2020 stock market crash. Evidence from S&P1500. Finance research letters, 38, 101690.

Mittal, S., & Sharma, D. (2021). The impact of COVID-19 on stock returns of the Indian healthcare and pharmaceutical sector. Australasian Accounting, Business and Finance Journal, 15(1), 5-21.

Ahmed, D., Neema, R., Viswanadha, N., & Selvanambi, R. (2022). Analysis and Prediction of Healthcare Sector Stock Price Using Machine Learning Techniques: Healthcare Stock Analysis. International Journal of Information System Modeling and Design (IJISMD), 13(9), 1-15.

Alam, M. M., Wei, H., & Wahid, A. N. (2021). COVID‐19 outbreak and sectoral performance of the Australian stock market: An event study analysis. Australian economic papers, 60(3), 482-495.

Handler, A., Singh, M., Narro, J., Caamano, M., & Chan-Lau, J. A. (2009). Risk factors definition. Retrieved May 16, 2020, from https://www.risk.net/definition/risk-factors.

Graham, John R; Smart, Scott B.; and Megginson, William J. (2010). Corporate Finance (third ed.). Mason OH: South-Western Cengage Learning. p. 387. ISBN 9780324782967.

Wikipedia contributors. (2022, August 5). Beta (finance). Wikipedia. https://en.wikipedia.org/wiki/Beta_(finance)#:%7E:text=In%20finance%2C%20the%20beta%20(%CE%B2,is%20added%20in%20small%20quantity.

Why the Price/Earnings-to-Growth Ratio Matters. (2021, October 6). Investopedia. https://www.investopedia.com/terms/p/pegratio.asp.

Fernandes, Nuno (2014). Finance for executives: a practical guide for managers. NPV Publishing. ISBN 978-989-98854-0-0. OCLC 878598064.